Global Med Technologies(R), Inc. Retains The Investor Relations Group DENVER, Feb. 1 /PRNewswire-FirstCall/ -- Global Med Technologies(R), Inc. ("Global Med") (OTC:GLOB) (BULLETIN BOARD: GLOB) has engaged The Investor Relations Group, Inc. ("IRG"), based in New York City, to serve as its financial relations company. (Logo: http://www.newscom.com/cgi-bin/prnh/20040226/GLOBALMEDLOGO) IRG will strive to increase investor awareness of Global Med within the U.S. market by individually and personally introducing Global Med and its management to pre-qualified investment professionals. "We are very pleased with Global Med's progress in the domestic and international market place. Our revenues in the third quarter were up 40% from the comparable quarter in 2003. Our business continues to trend higher, as we recently announced that our products are installed at over 300 locations, and are well positioned to drive double digit growth and positive cash flow from operations on an annual basis," said Michael I. Ruxin, M.D., Chairman and CEO of Global Med Technologies. Dr. Ruxin added, "In line with this progress, management is focused on maximizing shareholder value. A key component of this effort will be to increase investor awareness of Global Med. We look forward to working with the IRG team to achieve this goal." In the future, U.S. investor inquiries relating to Global Med can be directed to The Investor Relations Group, New York, NY, Telephone: (212) 825-3210, E-Mail: . About Global Med Technologies(R), Inc. Global Med Technologies, Inc., based in Denver, Colorado, designs, develops, markets and supports information management software products for blood banks, hospitals, centralized transfusion centers and other healthcare related facilities. Its Wyndgate Technologies(R) division is a leading supplier of information management systems to U.S. and international blood centers and hospital transfusion centers. Current clients of Wyndgate's products and services manage more than 3 million units of blood, or over 22% of the U.S. blood supply, each year. Wyndgate's products are also being implemented in Canada, the Caribbean and sub-Sahara Africa. Together, the SafeTrace Tx(R)* advanced transfusion management system and the SafeTrace(R) donor management system provide Vein-to-Vein(R) tracking from donor collection to patient transfusion. Please visit the Global Med website at: http://www.globalmedtech.com/. *Patent Pending About The Investor Relations Group The Investor Relations Group, Inc., (IRG) founded in 1996, represents select publicly traded companies, with a unique specialization for assisting those in the small-cap sector. IRG arranges one-on-one meetings for its portfolio companies with pre-qualified money managers handling investment portfolios that range from $10 million to $10 billion+, selected from its proprietary contact base of over 27,000 qualified fund managers who have an investing history in small cap stocks. IRG is a full-service corporate communications company offering services for its portfolio companies that include writing all press releases and shareholder communications, and serving as primary contact for the investing community. IRG also houses a full-service public relations arm that specializes in building awareness of its companies within the financial and trade media, as well as the public at large. For further information, please visit the company's website at http://www.investorrelationsgroup.com/. This news release may include statements that constitute forward-looking statements, usually containing the words "believe," "estimate," "project," "expects" or similar expressions. These statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. Forward-looking statements inherently involve risks and uncertainties that could cause actual results to differ materially from the forward-looking statements. By making these forward-looking statements, the Company undertakes no obligation to update these statements for revisions or changes after the date of this news release. http://www.newscom.com/cgi-bin/prnh/20040226/GLOBALMEDLOGO http://photoarchive.ap.org/ DATASOURCE: Global Med Technologies, Inc. CONTACT: Michael I. Ruxin, M.D. of Global Med Technologies, Inc., +1-303-238-2009; or Investor Relations, John Nesbett or Sari Clement, both of The Investor Relations Group, +1-212-825-3210 Web site: http://www.globalmedtech.com/

Copyright